ResearcherImmodulon Therapeutics (United Kingdom)No recent work listed
Laura Rosa Brunet
Matched on OpenAlex author ID A5000751761. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper
Papers 3
- Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer? Co-author DOI 10.1080/2162402x.2015.1112942↗
- IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer Co-author DOI 10.1186/2051-1426-2-s3-p83↗
- Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer Co-author DOI 10.1186/2051-1426-1-s1-p215↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thorsten Hagemann · 2 shared papers, 2013–2016 · strength 0.13
- Paper Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer? DOI 10.1080/2162402x.2015.1112942↗
- Paper Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer DOI 10.1186/2051-1426-1-s1-p215↗
- Satvinder Mudan · 1 shared paper, 2016 · strength 0.08
- Aurélien Marabelle · 1 shared paper, 2016 · strength 0.08
- Hilary Bilyard · 1 shared paper, 2014 · strength 0.06
- Frances Macintosh · 1 shared paper, 2014 · strength 0.06
- Angus George Dalgleish · 1 shared paper, 2014 · strength 0.06
- Androulla Elia · 1 shared paper, 2013 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.